keyboard_arrow_up
keyboard_arrow_down
NerVFIX® nerve regeneration conduit
NerVFIX® is a nerve regeneration conduit, decellularized, freeze-dried and sterile made of allogeneic artery and vein from umbilical cord. It is authorized by the Paul-Ehrlich-Institute (the German competent authority) and authorized by the ANSM for interventions on peripheral nerves regeneration in 2 ways:
- as a conduit for a gap < 2 cm
- as a wrapping after the peripheral nerve is sutured
Its biological tubular structure boosts a fast axonal regrowth and oriented with remyelinisation (sensory and motor recovery as part of concept proof on animals).
It is biocompatible and resorbable in 8 to 12 weeks (pre-clinical animal cases).
 |
The NerVFIX® allogeneic conduit is composed of: - on the outside : the vascular wall from the umbilical vessel turned inside out. - on the inside : Wharton jelly, a gelatinous substance from the umbilical cord. |
|
 |
It doesn't collapse, the vascular wall being on the outside and the Wharton jelly on the inside. It is flexible, can be cut and sutured. It is delivered ready-to-use and can be stocked for 5 years at room temperature. |
|
 |
The NerVFIX® conduit is made of veins and artery from the umbilical cord, collected during birth labor in the strict respect of the Good Practices of Tissue collection and the Bioethical laws. It is treated by the French Tissue Bank TBF according to the AMTRIX® production and safety procedure. |
NerVFIX® is a nerve regeneration conduit, decellularized, freeze-dried and sterile made of allogeneic artery and vein from umbilical cord. It is authorized by the Paul-Ehrlich-Institute (the German competent authority) and authorized by the ANSM for interventions on peripheral nerves regeneration in 2 ways:
- as a conduit for a gap < 2 cm
- as a wrapping after the peripheral nerve is sutured
Its biological tubular structure boosts a fast axonal regrowth and oriented with remyelinisation (sensory and motor recovery as part of concept proof on animals).
It is biocompatible and resorbable in 8 to 12 weeks (pre-clinical animal cases).